Parathyroid hormone-related protein (PTH-rP)-associated hypercalcemia in a patient with an atypical chronic lymphocytic leukemia

Netherlands Journal of Medicine

Volumn 54, Issue 1, 1999, Pages 21-26

  Vlasveld, L Th ^a   Pauwels, P ^b   Ermens, A A M ^a   Aarnoudse, W H ^a   Ooms, H W A ^a   Haak, H R ^a  

^a Diaconessenhuis Ds Th F ^*  (Netherlands)

^b Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

Author keywords

Atypical chronic lymphocytic leukemia; Chronic lymphocytic leukemia; Hypercalcemia; Parathyroid hormone related protein

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FUROSEMIDE; PAMIDRONIC ACID; PARATHYROID HORMONE RELATED PROTEIN; PREDNISONE; SODIUM CHLORIDE; VINCRISTINE;

AGED; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; DEATH; ESCHERICHIA COLI; HUMAN; HYPERCALCEMIA; LYMPHOCYTE; MALE; SALMONELLA; SEPTIC SHOCK; SEPTICEMIA; SINUSITIS; STREPTOCOCCUS INFECTION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; FATAL OUTCOME; HUMANS; HYPERCALCEMIA; LEUKEMIA, B-CELL, CHRONIC; MALE; PARATHYROID HORMONE; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE FRAGMENTS; PREDNISONE; PROTEINS; SEPSIS; VINCRISTINE;

EID: 0032932911     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(98)00099-0     Document Type: Article

References (28)

1. Barri Y.M., Knochel J.P. Hypercalcemia and electrolyte disturbances in malignancy. Hematol Oncol Clin N America. 10:1996;775-790.
2. Kanis J.A., O'Rourke N., McCloskey E.V. Consequences of neoplasia induced bone resorption and the use of clodronate (review). Int J Oncol. 5:1994;713-731.
3. Van Oosterom AT, Dirix LY, Van Rijswijk R. Metabolic disturbances. In: Peckham, M, Pinedo HM, Veronesi U (eds.), Oxford Textbook of Oncology, Oxford, New York, Tokyo: Oxford Medical Publications, 1996:2201-2227.
4. Stewart AF. Humoral hypercalcemia of malignancy. In: Primer on the metabolic bone diseases and disorders of mineral metabolism. 3rd edition, Philadelphia, New York, Lippincott-Raven Press, 1996:198-203.
5. Suva L.J., Winslow G.A., Wettenhall R.E.H.et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science. 237:1987;893-896.
6. Firkin F., Seymour J.F., Watson A.-M, Grill V., Martin T.J. Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy. Br J Haematol. 94:1996;486-492.
7. Seymour J.F., Gagel R.F. Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's disease. Blood. 82:1993;1383-1394.
8. Van de Casteele M., Verhoef G.E., Demuynck H., Zachee P., Boogaerts M.A. Hypercalcemia, monoclonal protein, and osteolytic bone lesion in chronic lymphocytic leukemia. Ann Hematol. 69:1994;79-80.
9. Seymour J.F., Khouri I.F., Champlin R.E., Keating M. Refractory chronic lymphocytic leukemia complicated by hypercalcemia treated with allogeneic bone marrow transplantation. Am J Clin Oncol. 17:1994;360-368.
10. Roodman G.D. Mechanisms of bone lesions in multiple myeloma and lymphoma. Cancer. 80:1997;1557-1563.
11. Fain O., M'Selmi A.E., Dosquet C.et al. Hypercalcaemia in B-cell chronic lymphocytic leukemia. Br J Haematol. 87:1994;856-858.
12. Seymour J.F., Keating M.J. Parathyroid hormone related protein in hypercalcaemia in CLL. Br J Haematol. 89:1995;685-686.
13. Bennett J.M., Catovsky D., Daniel M.-T.et al. Proposals for the classification of chronic (mature) B and T lymphoid leukemias. J Clin Pathol. 42:1989;567-584.
14. Matutes E., Oscier D., Garcia-Marco J.et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol. 92:1996;382-388.
15. O'Brien S., del Giglio A., Keating M. Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood. 85:1995;307-318.
16. Oscier D.G., Matutes E., Copplestone A.et al. Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12. Br J Haematol. 98:1997;934-939.
17. Criel A., Verhoef G., Vlietninck R.et al. Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases. Br J Haematol. 97:1997;383-391.
18. Fegan C., Robinson H., Thompson P., Whittaker J.A., White D. Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease. Leukemia. 9:1995;2003-2008.
19. Döhmer H., Stilgenbauer S., James M.R.et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood. 89:1997;2516-2522.
20. Ratcliffe W.A. PTH-related protein (PTHrP) and hypercalcaemia of malignancy. In: Tumour-induced hypercalcaemia and its management. Int Congress Symp Series. 176:1991;33-43.
21. Strewler GJ, Nissenson RA. Parathyroid-hormone-related protein. In: Primer on the metabolic bone diseases and disorders of mineral metabolism. 3rd edition, Philadelphia, NY, Lippincott-Raven Press,1996:71-73.
22. Martin T.J. Actions of parathyroid hormone-related peptide and its receptor. N Eng J Med. 335:1996;736-738.
23. Segre GV, Brown EM. Secretion, circulating heterogeneity, and metabolism of parathyroid hormone. In: Primer on the metabolic bone diseases and disorders of mineral metabolism. 3rd edition, Philadelphia, NY, Lippincott-Raven Press, 1996:63-67.
24. Rankin W., Grill V., Martin T.J. Parathyroid hormone-related protein and hypercalcemia. Cancer. 80:1997;1564-1571.
25. Guise T.A. Parathyroid hormone-related protein and bone metastasis. Cancer. 80:1997;1572-1580.
26. Bilezikian J.P. Management of acute hypercalcemia. N Eng J Med. 326:1992;1196-1203.
27. Rogers M.J., Watts D.J., Russell R.G.G. Overview of bisphosphonates. Cancer. 80:1997;1652-1660.
28. Gurney H., Grill V., Martin T.J. Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcemia. Lancet. 341:1993;1611-1613.